Literature DB >> 10442250

A study of salivary secretion in Parkinson's disease.

H Bagheri1, C Damase-Michel, M Lapeyre-Mestre, S Cismondo, D O'Connell, J M Senard, O Rascol, J L Montastruc.   

Abstract

Hypersialorrhea is frequently reported in patients with idiopathic Parkinson's Disease (PD). Excessive production of saliva, swallowing difficulties, or both could explain this complaint. Dopamine (DA) has been shown to modulate salivary secretion in a number of vertebrate and invertebrate species. The present study was performed to compare the unstimulated salivary flow in 83 patients with PD (8 untreated and 75 treated with levodopa + DA agonist) and in 65 age- and sex-matched control subjects. The Mann-Whitney U-test showed a significantly lower salivary flow in treated patients with PD (535 +/- 42 mg/2 min) (p < 0.002) and de novo patients (447 +/- 141) (p < 0.03) compared to controls (834 +/- 68 mg/2 min) with no relation with age or sex. Finally, the present study of reduced salivary flow in PD suggests that complaints of hypersialorrhea are not caused by a salivary defect, but could be explained by difficulties in swallowing. The decrease in salivary flow could be explained by autonomic dysfunction in PD.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10442250

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN: 0362-5664            Impact factor:   1.592


  28 in total

1.  Impact of drooling in Parkinson's disease.

Authors:  Johanna G Kalf; Anne M Smit; Bastiaan R Bloem; Machiel J Zwarts; Marten Munneke
Journal:  J Neurol       Date:  2007-08-02       Impact factor: 4.849

2.  Salivary α-synuclein and DJ-1: potential biomarkers for Parkinson's disease.

Authors:  Ivana Devic; Hyejin Hwang; John Scott Edgar; Kenneth Izutsu; Richard Presland; Catherine Pan; David R Goodlett; Yu Wang; Jeff Armaly; Vitor Tumas; Cyrus P Zabetian; James B Leverenz; Min Shi; Jing Zhang
Journal:  Brain       Date:  2011-02-24       Impact factor: 13.501

Review 3.  The option of sonographic guidance in Botulinum toxin injection for drooling in Parkinson's disease.

Authors:  Wolfgang H Jost
Journal:  J Neural Transm (Vienna)       Date:  2015-07-03       Impact factor: 3.575

Review 4.  Drooling in Parkinson's disease: a review.

Authors:  Prachaya Srivanitchapoom; Sanjay Pandey; Mark Hallett
Journal:  Parkinsonism Relat Disord       Date:  2014-08-27       Impact factor: 4.891

5.  Significantly reduced salivary nitric oxide synthesis in patients with Parkinson's disease.

Authors:  Jasminko Huskić; Alma Paperniku; Azra Husić; Faruk Alendar; Nedzad Mulabegović
Journal:  Bosn J Basic Med Sci       Date:  2005-08       Impact factor: 3.363

Review 6.  [Treatment of sialorrhea with botulinum toxin: an overview].

Authors:  J Hagenah; K G Kahl; S Steinlechner; R Lencer; C Klein
Journal:  Nervenarzt       Date:  2005-04       Impact factor: 1.214

Review 7.  [Gastrointestinal dysfunction in idiopathic Parkinson's disease].

Authors:  K Del Tredici; W H Jost
Journal:  Nervenarzt       Date:  2012-10       Impact factor: 1.214

8.  Long-lasting benefits of botulinum toxin type B in Parkinson's disease-related drooling.

Authors:  Giovanni Lagalla; Marzia Millevolte; Marianna Capecci; Leandro Provinciali; Maria Gabriella Ceravolo
Journal:  J Neurol       Date:  2009-04-23       Impact factor: 4.849

9.  Pathophysiology underlying drooling in Parkinson's disease: oropharyngeal bradykinesia.

Authors:  Mehmet Karakoc; Mehmet Ilker Yon; Gul Yalcin Cakmakli; Ersin Kasim Ulusoy; Aydin Gulunay; Nese Oztekin; Fikri Ak
Journal:  Neurol Sci       Date:  2016-09-09       Impact factor: 3.307

10.  Spontaneous Swallowing during All-Night Sleep in Patients with Parkinson Disease in Comparison with Healthy Control Subjects.

Authors:  Irem Fatma Uludag; Bedile Irem Tiftikcioglu; Cumhur Ertekin
Journal:  Sleep       Date:  2016-04-01       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.